| Literature DB >> 30131467 |
Elżbieta U Stolarczyk1, Marta Łaszcz2, Andrzej Leś3,4, Marek Kubiszewski5, Krzysztof Kuziak6, Katarzyna Sidoryk7, Krzysztof Stolarczyk8.
Abstract
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active antiEntities:
Keywords: AB-abiraterone; AuNPs-gold nanoparticles; NP-based system; Raman spectroscopy; conjugates; density functional theory; powder diffraction; thermogravimetry; transmission electron microscopy
Year: 2018 PMID: 30131467 PMCID: PMC6164775 DOI: 10.3390/nano8090641
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Structures of abiraterone acetate (AB acetate) and abiraterone (AB). Four rings of the androsta-5,16-dien-3β-ol moiety are denoted as A, B, C, and D.
Figure 2Control of abiraterone in the supernatant by the UV-Vis technique: after one centrifugation (red line); after two centrifugations (black line); after three centrifugations (blue line): below the limit of detection (LOD).
Figure 3UV-Vis spectra of the AuNPs–AB conjugate in pH 3.6: the blue line denotes reaction mixtures; the black line denotes nanoparticle precipitate.
Figure 4UV-Vis spectra of the AuNPs–AB conjugate in pH 7.4: the blue line denotes reaction mixtures; the black line denotes nanoparticle precipitate.
Surface Plasmon Resonance (SPR), Hydrodynamic Diameter (DLS), Mean Particle Diameter (TEM), average Au crystallite size (XRPD), and Zeta-Potential Values.
| AuNPs–AB | SPR | Diameter (DLS) | Diameter (TEM) | Au Crystallite Size | Zeta Potential, mV |
|---|---|---|---|---|---|
| nm | |||||
| pH 3.6 | 551 | 229 ± 16 | 30 (7–65) | 17 | −11 ± 1 |
| pH 7.4 | 565 | 260 ± 35 | 24 (11–40) | 9 | −13 ± 1 |
Figure 5TEM images and histograms of (A) AuNPs–AB pH 3.6 and (B) AuNPs–AB pH 7.4 particle size distribution.
Relative stability and binding energy of the Aun–AB conjugates and Aun–AB reduced models.
| Conjugate | Relative Stability 1) kcal/mol (kJ/mol) | Binding Energy 2) kcal/mol (kJ/mol) |
|---|---|---|
|
| ||
| Au5–(N)abiraterone | 0.0 | −27.6 (−115.5) |
| Au5–(OH)abiraterone | 10.1 (42.1) | −14.5 (−60.6) |
| Au13–(N)abiraterone | 0.0 | −18.3 (−76.4) |
| Au13–(OH)abiraterone | 9.7 (40.6) | −8.6 (−36.1) |
|
| ||
| Au13–(N)pyridine | - | −17.3 (−72.2) |
| Au13–(OH)cyclohexenol | - | −5.3 (−22.2) |
| Au20–(N)pyridine | - | −18.7 (−77.0) |
| Au20–(OH)cyclohexenol | - | −9.2 (−38.5) |
|
| ||
| Au5–(N)abiraterone acetate | 0.0 | −25.9 (−108.3) |
| Au5–(O=C)abiraterone acetate | 10.5 (44.1) | −15.9 (−66.6) |
|
| ||
| [Au5–(NH)abiraterone]1+ | 0.0 | −7.8 (−32.5) |
| [Au5–(OH)abiraterone]1+ | 11.9 (49.7) | −12.8 (−53.5) |
1) The relative stability is based on the comparison of the calculated free energies of the conjugate. 2) The binding energy is calculated for the conjugates using the counterpoise correction for the intermolecular interactions.
Figure 6Identification of the crystalline phases in the lyophilized mixtures.
Figure 7Diffractograms of the AuNPs–AB conjugates obtained in pH 3.6 and 7.4. Insert: a diffractogram of the nanoparticle obtained in pH 7.4 after purification in the range of 30–50°.
Figure 8A comparison of the theoretical Raman spectra of AB, Au13–(N)AB, and Au13–(OH)AB in the range from 1800 to 1000 cm−1.
A description of characteristic bands from the theoretical spectra of AB, Au13–(N)AB, and Au13–(OH)AB.
| AB | Au13–(N)AB 1) | Au13–(OH)AB | |||
|---|---|---|---|---|---|
| Wavenumbers, (cm−1) | |||||
| 1740 | C=C (B) 2) | 1740 | C=C (B) | 1737 | C=C (B) |
| 1667 | mainly C=C (D) 3) + pyridine | 1665 | mainly C=C (D) + pyridine | 1667 | mainly C=C (D) + pyridine |
| 1640 | pyridine | 1641 | mainly pyridine + C=C (D) | 1640 | pyridine |
| 1612 | mainly pyridine + C=C (D) | 1617 | 1612 | mainly pyridine + C=C (D) | |
| 1078 | whole AB molecule | 1089 | entire AB molecule | 1076 | entire AB molecule |
| -- | -- | -- | -- | 1052 | steroid moiety with OH without pyridine |
| 1040 | whole AB molecule | 1043 | mainly pyridine + steroid moiety with OH | 1039 | mainly pyridine + steroid moiety |
1) wavenumbers for the Au5–(N)AB model are the same. 2), 3) description of the AB rings from Figure 1.
Figure 9A comparison of the Raman spectra of three AB polymorphs. From the top to the bottom polymorphic spectra I, II, and III are shown.
Figure 10A comparison of the Raman spectra of the nanoparticles obtained in pH 3.6 and 7.4.
A collection of the wavenumbers from the theoretical and experimental Raman spectra of AB and the nanoparticles.
| Theoretical | Experimental | |||||
|---|---|---|---|---|---|---|
| AB | Au13–(N)AB | Form I | Form II | Form III | AuNPs–(N)AB | AuNPs–(N)AB |
| Wavenumbers, (cm−1) | ||||||
| 1740 | 1740 | 1663 | 1669 | 1664 | 1658 | -- |
| 1667 | 1664 | 1594 | 1604 | 1597 | 1590 | 1585 |
| 1640 | 1641 | -- | 1584 | 1586 | 1565 | -- |
| 1612 | 1617 | 1565 | 1564 | 1564 | 1534 | 1519 |
| 1078 | 1089 | 1049 | 1051 | 1055 | 1057 | -- |
| 1040 | 1043 | 1023 | 1025 | 1023 | 1028 | 1028 |
Figure 11A diagnostic fragment of the NMR spectrum of the abiraterone nanoparticles.
Figure 12DPV voltammograms (pulse amplitude 50 mV, pulse width 50 ms, potential step 16 mV) recorded using GCE electrodes in deoxygenated DMSO solutions with 0.1 M TBAHFP (green dashed dotted line) background without AB, (red dotted line) with 100 μM AB, and (blue solid line) the AuNPs–AB pH 3.6 conjugate and (dark dashed line) the AuNPs–AB pH 7.4 conjugate transferred to a pure supporting electrolyte.